Skip to content
← Back to this collection

PUBLICATIONS · 26050650

IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Leukemia
Publication date
2015 Nov
First author
Clappier E

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Clappier E
      type
      Author
    2. name
      Grardel N
      type
      Author
    3. name
      Bakkus M
      type
      Author
    4. name
      Rapion J
      type
      Author
    5. name
      De Moerloose B
      type
      Author
    6. name
      Kastner P
      type
      Author
    7. name
      Caye A
      type
      Author
    8. name
      Vivent J
      type
      Author
    9. name
      Costa V
      type
      Author
    10. name
      Ferster A
      type
      Author
    11. name
      Lutz P
      type
      Author
    12. name
      Mazingue F
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Clappier E
      type
      Author
    2. name
      Grardel N
      type
      Author
    3. name
      Bakkus M
      type
      Author
    4. name
      Rapion J
      type
      Author
    5. name
      De Moerloose B
      type
      Author
    6. name
      Kastner P
      type
      Author
    7. name
      Caye A
      type
      Author
    8. name
      Vivent J
      type
      Author
    9. name
      Costa V
      type
      Author
    10. name
      Ferster A
      type
      Author
    11. name
      Lutz P
      type
      Author
    12. name
      Mazingue F
      type
      Author
    bibliography ids
    1. nci-bib-8e39a86e4993eb91fc62202a
    book metadata
    content sha256
    e466bb158d779c36b291a08ccf3a3e6bbc758a9fcb329322acb033c7806fdb1b
    document type
    citation
    dois
    1. 10.1038/leu.2015.134
    electronic publication date
    display
    2015 Jun 8
    precision
    day
    year
    2015
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:26050650
    immutable id
    pubmed:26050650@e466bb158d779c36b291a08ccf3a3e6bbc758a9fcb329322acb033c7806fdb1b
    journal
    abbreviation
    Leukemia
    issn electronic
    1476-5551
    issn print
    0887-6924
    issue
    11
    name
    Leukemia
    nlm unique id
    8704895
    pages
    2154-61
    volume
    29
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      26050650
      provenance
      batch id
      74265f1b641f04cf2d05
      provider
      NCBI PubMed ESummary
      record sha256
      6d841693b2a5000f079c7f512a226600100a39c59e35fd9e82ed7a0737e731a8
      response sha256
      193df6bb6d2ac41af73dc445bf8171fe8076a8c8a5e98882a3d6a1ada428b0f0
      retrieved at
      2026-09-09T23:47:10.134322+00:00
      publication date
      display
      2015 Nov
      precision
      month
      year
      2015
      publication types
      1. Journal Article
      2. Randomized Controlled Trial
      3. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/26050650/
      title
      IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951.

      Preserved source evidence · Independent clinical review pending · Not medical advice